We serve Chemical Name:methyl 1-bromocyclohexane-1-carboxylate CAS:3196-23-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 1-bromocyclohexane-1-carboxylate
CAS.NO:3196-23-4
Synonyms:methyl 1-bromocyclohexanecarboxylic acid;methyl 1-bromocyclohexylcarboxylate;MFCD00134214;methyl 1-bromo-cyclohexane-1-carboxylate;Methyl 1-bromocyclohexanecarboxylate;methyl 1-bromocyclohex-1-yl-1-carboxylate;1-Bromcyclohexancarbonsaeure-methylester
Molecular Formula:C8H13BrO2
Molecular Weight:221.09200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:115-116ºC19 mm Hg(lit.)
Density:1.39 g/mL at 25ºC(lit.)
Index of Refraction:n20/D 1.493(lit.)
PSA:26.30000
Exact Mass:220.01000
LogP:2.25720
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3265 8/PG 2
Packing Group:III
Contact us for information like methyl 1-bromocyclohexanecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Bromcyclohexancarbonsaeure-methylester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Bromcyclohexancarbonsaeure-methylester Use and application,MFCD00134214 technical grade,usp/ep/jp grade.
Related News: Today’s announcement is strongly aligned to IDA Ireland’s Regional pillar and its continued commitment to winning jobs and investment in regional locations. I wish Charles River every success with this expansion.” (13E)-(9S,15R)-16,16-Dimethyl-9-hydroxy-15-(tetrahydropyran-2-yloxy)-13-prosten-18-ynoic Acid manufacturers IDA Ireland Executive Director Mary Buckley said: “Charles River is an employer of long-standing in Co. Mayo. The enhancement of its product lines and the development of additional capability at the Ballina facility is most welcome. 2,2′,2′,2”-(((((1,4,7,10,13-pentaoxacyclohexadecane-15,15-diyl)bis(methylene))bis((carboxymethyl)azanediyl))bis(ethane-2,1-diyl))bis(azanetriyl))tetraacetic acid suppliers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. 2-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)isoindoline-1,3-dione vendor & factory.
